CLSI MR15
Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa, 1st Edition
This CLSI rationale document is based on data compiled by the CLSI Working Group on Piperacillin-Tazobactam to reassess piperacillin-tazobactam breakpoints against Pseudomonas aeruginosa.
This edition of the document was corrected in February 2024. Read the correction notices by accessing the link above, and learn more about our correction process here.
This document is available in electronic format only.
Member price:
List Price:Details
Chairholder: Romney M. Humphries, PhD, D(ABMM), FIDSA; Pranita D. Tamma, MD, MHS
Date of Publication: January 2, 2024
Order Code PDF: CLSI MR15Ed1E
ISBN Number: 978-1-68440-212-0
Order Code Print: print not available
Edition: First
Pages: 12